Recipient Organization
VIRGINIA POLYTECHNIC INSTITUTE
(N/A)
BLACKSBURG,VA 24061
Performing Department
HUMAN NUTRITION & FOODS
Non Technical Summary
Weight loss often results in loss of bone mineral. This project evaluates changes in biomarkers of inflammation and bone metabolism as well as bone mineral in overweight premenopausal women who lose weight.
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Goals / Objectives
The primary aim of this study is to evaluate the changes in biomarkers of inflammation and bone metabolism as well as bone mineral density (BMD) in overweight premenopausal women who follow a low-fat, high-carbohydrate diet with a daily milk chocolate snack compared to a low-fat, high-carbohydrate diet with a daily dark chocolate snack designed to induced weight loss. To achieve Specific Aim #1, four objectives will be met. During an 18-week diet intervention period: (1) changes in biochemical markers of inflammation, including tumor necrosis factor-alpha, interleukin-1, interleukin-6, and C-reactive protein will be measured; (2) changes in biomarkers of bone turnover, including bone formation (serum osteocalcin) and bone resorption (serum N-telopeptide) will be measured; (3) changes in biomarkers of mineral metabolism (serum and urinary calcium and phosphorus) will be measured; (4) BMD of the total body, lumbar spine, total proximal femur (hip), and total forearm will
be measured. The secondary aim of this study is to compare changes in blood lipid profiles among overweight premenopausal women who follow a low-fat, high-carbohydrate diet with a daily milk chocolate snack compared to a low-fat, high-carbohydrate diet with a daily dark chocolate snack designed to induce weight loss. To achieve Specific Aim #2, one objective will be met. During an 18-week diet intervention period: (5)changes in serum total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglycerides will be measured.
Project Methods
Thirty premenopausal women, aged 30 to 45 years, will participate in this 18-week study. A randomized, controlled trial of weight loss will be conducted. The base diet will include a low-fat, high-carbohydrate approach. Women will follow a weight loss diet that incorporates milk chocolate or dark chocolate into the food intake plan or will follow a weight loss diet that does not include chocolate (control diet). Women will engage in weekly nutrition education and motivation sessions. They will complete 4-day dietary intake records at intervals throughout the study. Four testing sessions will take place: baseline and weeks 6, 12, and 18. During each testing session, women will have their body weights and waist and hip circumferences measured; will provide blood and urine samples; and will have body composition, including bone mineral, measured. From blood samples, serum tumor necrosis factor-alpha, interleukin-1, interleukin-6, C-reactive protein, N-telopeptide, and
osteocalcin will be measured. In addition, serum calcium and phosphorus will be determined as will serum total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglycerides. Urinary calcium and phosphorus will be determined. Dual-energy X-ray absorptiometry will be used to measure bone mineral density of the total body, lumbar spine, hip, and forearm in women as they lose weight. From the total body data, body lean mass and fat mass will be determined.